Human Gene Sequencing Market Report 2022: New Diagnoses, Wellness and Prevention & Fertility Technology All Driving Market Growth
Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Human Gene Sequencing Markets, Strategies & Trends - Forecasts by Application, by Technology, by Workflow, by Product, and by Country, with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.
The plummeting costs for Genome Sequencing is creating a gold rush. New consumers, new technologies, new market niches. It is reminiscent of the birth of the internet industry; a wide range of well funded players are racing for market share on a global stage. This report forecasts the market size out to 2026. The report includes detailed breakouts for 14 countries and 5 regions.
Key Topics Covered:
1 Market Guides
2 Introduction and Market Definition
3 Global Listing of Sequencer Installed Base - Location & Contacts
4 Market Overview
4.1 Market Participants Play Different Roles
4.2 Human Gene Sequencing -Markets, Examples and Discussion
4.2.1 Inherited Disease - Not what it used to be
4.2.2 Newborn Screening - The Standard of Care
4.2.3 NIPT - We've Only Just Begun
4.2.4 Oncology - Understanding Two Worlds
4.2.5 Pharmacogenomics
4.2.6 Direct To Consumer - More Than Meets the Eye
4.2.6.1 DTC - How Many Segments?
4.3 Industry Structure
4.3.1 Hospital's Testing Share
4.3.2 The Rise of the Sequencing Lab
4.3.3 Sequencing as a Commodity
4.3.4 Informatics
4.3.5 Instrument Manufacturer Role
4.3.6 Healthcare Industry Impacts - Still Struggling
4.3.7 Can the Healthcare Industry Adapt?
4.3.8 Genetic Counselling as an Industry
4.3.9 Sequencing Adoption and Cannibalization
5 Market Trends
5.1 Factors Driving Growth
5.1.1 New Diagnoses
5.1.2 Wellness and Prevention
5.1.3 Fertility Technology
5.1.4 Cancer - Screening, Management and Monitoring
5.2 Factors Limiting Growth
5.2.1 Increased Competition Lowers Price
5.2.2 Lower Costs
5.2.3 Healthcare Cost Concerns Curtail Growth
5.2.4 Wellness has a downside
5.3 Sequencing Instrumentation
3.3.1 Instrumentation Tenacity
3.3.2 Declining Cost of Instruments Changes Industry Structure
3.3.3 Listing of Current Instrument Specifications
5.3.1 Long Reads - Further Segmentation
5.3.2 Linked Reads
5.3.3 New Sequencing Technologies
6 Human Gene Sequencing Recent Developments
7 Profiles of Key Companies
8 The Global Market for Human Genome Sequencing
8.1 Global Market Overview by Country
8.2 Global Market by Application - Overview
8.3 Global Market by Technology - Overview
8.4 Global Market by Workflow - Overview
8.5 Global Market by Product - Overview
9 Market Sizes by Application
9.1 Hereditary Gene Sequencing Market
9.2 NIPT Gene Sequencing Market
9.3 Oncology Market
9.4 Psychology Market
9.5 WGES Gene Sequencing Market
9.6 Pharmacogenomics Market
9.7 DTC Gene Sequencing Market
9.8 Research Gene Sequencing Market
9.9 Other Application Market
10 Market Sizes by Technology
10.1 Sanger Sequencing Market
10.2 NGS/2G Market
10.3 3G/Long Market
10.4 Other Technology Market
11 Market Sizes by Workflow
11.1 Sequencing Market
11.2 Sample Prep Market
11.3 Analysis Market
12 Market Sizes by Product
12.1 Instruments Market
12.2 Consumables Market
12.3 Software & Services Market
13 Vision of the Future of Human Gene Sequencing
Companies Mentioned
10x Genomics, Inc
23andME Inc
Abbott Diagnostics
AccuraGen Inc
Adaptive Biotechnologies
Admera Health, LLC
Agena Bioscience, Inc
Agilent
Akonni Biosystems
Ancestry.com LLC
Anchor Dx
Aperiomics
Arc Bio
ArcherDx, Inc
ARUP Laboratories
Asuragen
Baylor Miraca Genetics Laboratories
Beckman Coulter Diagnostics
Becton, Dickinson and Company
BGI Genomics Co. Ltd
Bio-Rad Laboratories, Inc
Bio-Techne
Bioarray Genetics
Biocept, Inc
Biodesix Inc
BioFluidica
BioGenex
Biolidics Ltd
bioMerieux Diagnostics
Bioneer Corporation
C2i Genomics
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Centogene
Cepheid (now Danaher)
Chronix Biomedical
Circulogene
Clinical Genomics
Color Genomics
Complete Genomics, Inc. - A BGI Company
Cynvenio
Dante Labs
Datar Cancer Genetics Limited
Diasorin S.p.A
Epic Sciences
Epigenomics AG
Eurofins Scientific
Excellerate Bioscience
Exosome Diagnostics
Fabric Genomics
Fluidigm Corp
Foundation Medicine
Freenome
FUJIFILM Wako Diagnostics
Fujirebio
Fulgent Genetics
MDx Health
Medgenome
Meridian Bioscience
Mesa Biotech
MIODx
miR Scientific
MNG Labs
Molecular MD
NantHealth, Inc
Natera
Nebula Genomics
NeoGenomics
Novogene Bioinformatics Technology Co., Ltd
Omega Bioservices
OncoDNA
OpGen
ORIG3N, Inc
Origene Technologies
Oxford Nanopore Technologies
Panagene
Sure Genomics, Inc
Sysmex Inostics
Sysmex
Tempus Labs, Inc.
Thermo Fisher Scientific Inc
Veritas Genetics
Volition
For more information about this report visit https://www.researchandmarkets.com/r/hho1sn
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900